Cargando…

Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents

Antiplatelet aggregation agents have demonstrated clinical benefits in the treatment of ischemic stroke. In our study, a series of novel nitric oxide (NO)-donating ligustrazine derivatives were designed and synthesized as antiplatelet aggregation agents. They were evaluated for the inhibitory effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Han-Xu, Tian, Jian-Hui, Li, Hua-Yu, Wan, Xin, Zou, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144142/ https://www.ncbi.nlm.nih.gov/pubmed/37110589 http://dx.doi.org/10.3390/molecules28083355

Ejemplares similares

Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents
por: Ma, Shitang, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of New Ligustrazine Derivatives as Anti-Tumor Agents
por: Wang, Penglong, et al.
Publicado: (2012)

Design, Synthesis and Biological Evaluation of Ligustrazine-Flavonoid Derivatives as Potential Anti-Tumor Agents
por: Wang, Hui, et al.
Publicado: (2018)

Synthesis of N-arylmethyl Substituted Indole Derivatives as New Antiplatelet Aggregation Agents
por: Faghih Akhlaghi, Masoud, et al.
Publicado: (2014)

Amino Acid Derivatives of Ligustrazine-Oleanolic Acid as New Cytotoxic Agents
por: Chu, Fuhao, et al.
Publicado: (2014)

A Series of New Ligustrazine-Triterpenes Derivatives as Anti-Tumor Agents: Design, Synthesis, and Biological Evaluation
por: Xu, Bing, et al.
Publicado: (2015)

Meta-Analysis of the Clinical Effectiveness and Safety of Ligustrazine in Cerebral Infarction
por: Yu, Tian, et al.
Publicado: (2016)

Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer’s Disease
por: Wu, Wenhao, et al.
Publicado: (2018)

A Nitric Oxide-Releasing Heparin Conjugate for Delivery of a Combined Antiplatelet/Anticoagulant Agent
por: Suchyta, Dakota J., et al.
Publicado: (2014)

Effect of Ligustrazine on Endometrium Injury of Thin Endometrium Rats
por: Ye, Qing, et al.
Publicado: (2019)

Novel Nitric Oxide Donor Dinitroazetidine-Coumarin Hybrids as Potent Anti-Intrahepatic Cholangiocarcinoma Agents
por: Yu, Zhihui, et al.
Publicado: (2022)

Pharmacokinetic study on the effect of ligustrazine–tangeretin co‐administration on the pharmacokinetics of ligustrazine and its potential mechanism in rats
por: Liu, Dandan, et al.
Publicado: (2023)

Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents
por: Luan, Tian, et al.
Publicado: (2018)

Novel Homo-Bivalent and Polyvalent Compounds Based on Ligustrazine and Heterocyclic Ring as Anticancer Agents
por: Wang, Jiawen, et al.
Publicado: (2019)

Design, synthesis and biological evaluation of novel nitric oxide-donating podophyllotoxin derivatives as potential antiproliferative agents against multi-drug resistant leukemia cells
por: Zhang, Lei, et al.
Publicado: (2018)

N-Substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity
por: Mirfazli, Seyedeh Sara, et al.
Publicado: (2014)

Ligustrazine monomer against cerebral ischemia/reperfusion injury
por: Gao, Hai-jun, et al.
Publicado: (2015)

Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide–Donating Agent
por: Gresele, Paolo, et al.
Publicado: (2010)

Electrochemical Synthesis of Novel 1,3-Indandione Derivatives and Evaluation of Their Antiplatelet Aggregation Activities
por: Amidi, Salimeh, et al.
Publicado: (2013)

Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents
por: Huang, Xing, et al.
Publicado: (2018)

Protective effect of ligustrazine on oxidative stress and apoptosis following testicular torsion in rats
por: Chen, Songmao, et al.
Publicado: (2023)

Meta-Analysis of Preventive and Therapeutic Effects of Ligustrazine on Airway Remodeling in Asthmatic Rats
por: Hua, Yu-shuang, et al.
Publicado: (2022)

Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel Resistance
por: Chen, Jingyu, et al.
Publicado: (2016)

Synthesis of folate-chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells
por: Cheng, Lichun, et al.
Publicado: (2017)

Ligustrazine Inhibits the Migration and Invasion of Renal Cell Carcinoma
por: Zhang, Xufeng, et al.
Publicado: (2023)

Repurposing nitric oxide donating drugs in cancer therapy through immune modulation
por: Li, Chung-Yen, et al.
Publicado: (2023)

Antithrombotic effect of ligustrazine hydrochloride injection on the model of induced arteriovenous shunt thrombosis
por: Wang, Peng, et al.
Publicado: (2013)

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
por: Hannachi, Nadji, et al.
Publicado: (2020)

Ligustrazine Injection for Chronic Pulmonary Heart Disease: A Systematic Review and Meta-Analysis
por: Jian-sheng, Li, et al.
Publicado: (2012)

Ligustrazine inhibits the viability and motility of colon cancer cells
por: Chen, Xiaochao, et al.
Publicado: (2020)

Antiplatelet Aggregation Coumarins from the Leaves of Murraya omphalocarpa
por: Chia, Yi-Chen, et al.
Publicado: (2008)

Elucidating the Novel Mechanism of Ligustrazine in Preventing Postoperative Peritoneal Adhesion Formation
por: Yang, Lili, et al.
Publicado: (2022)

Ligustrazinyl amides: a novel class of ligustrazine-phenolic acid derivatives with neuroprotective effects
por: Li, Guoliang, et al.
Publicado: (2015)

Effect of ligustrazine on preventing contrast-induced nephropathy in patients with unstable angina
por: Ye, Ziliang, et al.
Publicado: (2017)

Design and synthesis of novel oridonin analogues as potent anticancer agents
por: Shen, Qing-Kun, et al.
Publicado: (2018)

Synthesis and Antiplatelet Aggregation Activity Evaluation of some 2-Aminopyrimidine and 2-Substituted-4,6-diaminopyrimidine Derivatives
por: Esfahanizadeh, Marjan, et al.
Publicado: (2015)

Synthesis and Protective Effect of New Ligustrazine-Benzoic Acid Derivatives against CoCl(2)-Induced Neurotoxicity in Differentiated PC12 Cells
por: Wang, Penglong, et al.
Publicado: (2013)

Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin as Potential Anti-Tumor Agents
por: Li, Dahong, et al.
Publicado: (2012)

Effects of ligustrazine on the expression of neurotransmitters in the trigeminal ganglion of a rat migraine model
por: Li, Hui, et al.
Publicado: (2021)

Meta-Analysis of Clinical Efficacy and Safety of Ligustrazine in the Treatment of Idiopathic Pulmonary Fibrosis
por: Wu, Xiaozheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vl7n75rcm8afnfqs3eaoe75779